Clinical Studies

EMRO is continuously striving to improve on the methods patients are treated. There are a number of areas in which we research and recruit, including:


Actively Enrolling Clinical Studies


Enrollment Criteria


ETTAU-03 #19522
Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria
· Age: ≥18
· Injectable treatment
· Symptoms of urticaria
Enrollment: M-F 7-7
CRC PIC 1044
PI: Thomas Hartka, MD
VIOLET #19850
Vitamin D to Improve Outcomes by Leveraging Early Treatment (VIOLET)
· Age: ≥18
· Enteric Vitamin D vs Placebo
· Intent to admit to ICU
· ARDS risk: PNA, aspiration, smoke inhalation, lung contusion, sepsis, pancreatitis, acute resp failure
Enrollment: M-F 7-7
CRC PIC 1044
PI: Enfield/Sochor
StandUP #19674
Evaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart Failure (STANDUP AHF)
· Age: ≥18
· History of HF + LVEF ≤40%
· BNP≥400
· SBP 105-160
· No ACS hosp w/i 90 days
Enrollment: M-F 7-7
CRC PIC 1044
PI: Chris Ghaemmaghami, MD
Cempra Pediatric Pneumonia #19962
A Phase 2/3, Randomized, Open-Label Study to Determine the Safety and Efficacy of Solithromycin in Pediatrics with CABP
· Age: 48 hours of systemic antibiotics Enrollment: M-F 7-7
CRC PIC 1044
PI: Josh Easter, MD
CIREN #20291

Crash Injury Research and Engineering Network Enrolling Center

· Age: Any
· MVC in a newer vehicle
· Severe injuries (1+ AIS ≥3 or 2+ AIS ≥2 injuries)
· Vehicle owner able to consent to be in database
Enrollment: M-F 7-7
CRC PIC 1044
PI: Tom Hartka, MD

Upcoming EMRO Studies 

Winter/Spring 2017-2018

  • Catalyst TBI Study – Dr. Easter
  • Alere/Abbott Rapid Diagnosis BNP Specimen Collection – Dr. Glass
  • Hemostatic Dressing – Dr. Charlton